Article Details
Retrieved on: 2021-05-03 05:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The biotechnology company reported $0.09 EPS for the quarter, beating analysts' consensus estimates of $0.05 by $0.04. Exelixis had a net margin of ...
Article found on: www.marketbeat.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here